drug
Augmentin
Marketedupdated 3mo agoby NeoPharma Inc
Approvedcommunity read0 votes
all catalysts(0)
nothing on the calendar yet
Trials studying Augmentin
- phase2A Pharmacokinetics and Safety Study of Augmentin ES-600 in Children With CAP and ABRS
- phase1A Pharmacokinetic Study of LP-001 in Children With a Bacterial Infection
- N/ALiveSpo Navax® Supports the Treatment of Acute Rhinosinusitis and Otitis Media
- phase1Amoxicillin-Clavulanic Acid 400 Mg-57 mg Chewable Tablets Under Non-Fasting Conditions
- phase1Amoxicillin-Clavulanic Acid 400 Mg-57 mg Chewable Tablets Under Fasting Conditions
- phase1600 mg Amoxicillin/42.9 mg Clavulanate Postassium /5 mL Suspension Under Fed Conditions
- phase1600 mg Amoxicillin/42.9 mg Clavulanate Postassium /5 mL Suspension Under Fasting Conditions
- phase4Study to Evaluate the Safety and Clinical Efficacy of Augmentin® Extra Strength-600 in Children With Acute Otitis Media in India
News(0)
no news has mentioned this drug yet
Data sources
last refreshed 34m ago
Found something off?
comments(0)
5-min edit window · permanent after that